-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Revenues history and growth rate from 2022 to 2024.
- Arcutis Biotherapeutics, Inc. Revenues for the quarter ending December 31, 2024 was $71.4M, a 428% increase year-over-year.
- Arcutis Biotherapeutics, Inc. Revenues for the twelve months ending December 31, 2024 was $197M, a 230% increase year-over-year.
- Arcutis Biotherapeutics, Inc. annual Revenues for 2024 was $197M, a 230% increase from 2023.
- Arcutis Biotherapeutics, Inc. annual Revenues for 2023 was $59.6M, a 1517% increase from 2022.